Association of Menopausal Status, Expression of Progesterone Receptor and Ki67 to the Clinical Response to Neoadjuvant Chemotherapy in Luminal Breast Cancer
Abstract Objective To identify the biomarkers of response to neoadjuvant chemotherapy in early luminal breast cancer. Methods A cross-sectional study that included all patients with early or locallyadvanced luminal breast cancer submitted to neoadjuvant chemotherapy between 2013 and 2014. Demographi...
Saved in:
Main Authors: | Leonardo Roberto da Silva (Author), Renato Flora Vargas (Author), Júlia Yoriko Shinzato (Author), Sophie Françoise Mauricette Derchain (Author), Susana Ramalho (Author), Luiz Carlos Zeferino (Author) |
---|---|
Format: | Book |
Published: |
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
by: Dorsay Sadeghian, et al.
Published: (2022) -
Progesterone and estradiol receptors and Ki-67 in the superficial and deep infiltrating endometriosis
by: Luiz F Sampaio Neto, et al.
Published: (2020) -
Prognostic Significance of Reduction in Ki67 Index After Neoadjuvant Chemotherapy in Patients With Breast Cancer in Kerman Between 2009 And 2014
by: Vahid Moazed, et al.
Published: (2018) -
Clinical and morphological aspects of neoadjuvant chemotherapy efficacy in patients with aggressive luminal HER2-negative breast cancer
by: D. A. Morozov, et al.
Published: (2022) -
Nova classificação dos carcinomas da mama: procurando o luminal A
by: Katia Piton Serra, et al.
Published: (2014)